Lung Cancer Prevention
|
|
|
- Janel Lawrence
- 7 years ago
- Views:
Transcription
1 Lung Cancer Prevention E. R. Greenberg MD Professor, Dartmouth Medical School Fred Hutchinson Cancer Research Center Sr. Epidemiologist: Cancer Research and Biostatistics
2 Lung Cancer Prevention What the Future Holds Tobacco Control Screening
3 What the Future Holds
4 Cancer Mortality Trends
5 Components of Cancer Death Trends
6 Trends in Tobacco Caused Deaths
7 A model describing stages of the tobacco epidemic based on data from developed countries
8 Age-standardized Incidence Rates for Lung Cancer
9 Tobacco Interventions Public policy initiatives Preventing initiation Cessation programs
10 Tobacco Interventions: Policy Policy interventions are most cost-effective. Taxation to raise prices Warning labels and advertising bans Prohibition of sales to minors Banning smoking in public places
11
12 Tobacco Control Milestones in the USA A change in policy from promoting tobacco to discouraging its use.
13 Cigarette consumption in the USA
14 Tobacco Interventions: Initiation Initiation usually occurs in teenage years. Smoking by celebrities encourages initiation among children. School-based educational programs often ineffective. Parental role important.
15 Tobacco Interventions: Cessation Adult smokers are usually strongly addicted. Brief interventions by doctors can be effective. Intervention requires screening to identify smokers and counseling. Prescription drugs may help smokers quit.
16 L. Solberg, et al. (2006) Repeated Tobacco- Use Screening and Intervention in Clinical Practice: Health Impact and Cost Effectiveness. Am J Prev Med; 31: Assessed cost effectiveness of tobacco-use screening and brief intervention. In USA, 2.47 million QALYs could be saved at a cost savings of $500 per smoker who receives the service.
17 LUNG CANCER SCRENING An unproven strategy.
18 Lung Cancer Screening Chest Xray and cytology RCTs have shown no benefit. PLCO study (USA) due to report in 2013.
19 Lung Cancer Screening Helical CT more sensitive than chest Xray. NLST (USA) in progress, RCT due European RCTs will complete soon after. ELCAP results from single-arm study 2006.
20 ELCAP INVESTIGATORS 2006 N Engl J Med. 355: Conclusions: Annual spiral CT screening can detect lung cancer that is curable.
21 ELCAP Study Screened 31,567 asymptomatic persons at risk for lung cancer using low-dose CT. Diagnosed lung cancer in 484 participants. 412 (85%) had clinical stage I lung cancer. Estimated 10-year survival rate was 88%.
22 Kaplan-Meier Survival Curves for 484 Participants with Lung Cancer and 302 Participants with Clinical Stage I Cancer Resected within 1 Month after Diagnosis The International Early Lung Cancer Action Program Investigators. N Engl J Med 2006;355:
23 Bach PB, et al. (2007). Computed tomography screening and lung cancer outcomes. JAMA. 297: Longitudinal analysis of 3246 smokers in 3 study centers Screened for lung cancer with CT Follow-up for a median of 3.9 years
24
25 Bach, et al. Conclusions Screening for lung cancer with low-dose CT may increase the rate of lung cancer diagnosis and treatment, but may not meaningfully reduce the risk of advanced lung cancer or death from lung cancer.
26 Need for RCTs of screening. Lead time bias causes spurious increase in survival. Length bias sampling causes preferential detection of more favorable tumors.
27 Natural history of disease
28 Lead time bias
29 Survival is always prolonged by early detection. (Unless the treatment kills you first.)
30
31 Length bias sampling
32 Screening preferentially detects slower growing (less aggressive) tumors.
33 Conclusions Tobacco control most cost-effective approach to preventing lung cancer. Policy approach to tobacco is essential strategy for low and middle income countries. Favorable results of ELCAP uninterpretable. CT screening evaluation will require an RCT.
MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850
LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock
Stephen R. Veach, M.D.
Stephen R. Veach, M.D. Memorial Sloan-Kettering Cancer Center International Oncology Programs 160 E. 53 rd Street New York, NY 10022 212-610 610-08780878 - tel 212-308 308-7063 - fax veachs@mskcc.org SCREENING
Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital
Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the
Clinical Trials and Screening: What You Need to Know
Scan for mobile link. Clinical Trials and Screening: What You Need to Know What is a Clinical Trial? At A Glance A clinical trial is a research study that tests how well new medical techniques work in
Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
Screening for asbestos-related lung cancer Nea Malila, Tony Miller, Riitta Sauni, Robert Smith, Kurt Straif, Tapio Vehmas
Screening for asbestos-related lung cancer Nea Malila, Tony Miller, Riitta Sauni, Robert Smith, Kurt Straif, Tapio Vehmas International Conference on Monitoring and Surveillance of Asbestos-Related Diseases
LUNG CANCER EVALUATION & TREATMENT. LungCancer. Prevention & Early Detection Save Lives. The Power Is Yours.
LUNG CANCER EVALUATION & TREATMENT LungCancer Prevention & Early Detection Save Lives. The Power Is Yours. Prevention Lung cancer. It s one of the most common cancers in both men and women more deadly
SLIDE 1: Good morning; I would like to thank the organizers for the opportunity to speak today on a significant issue the relationship between tobacco taxation and public health. Much of the background
SMOKING TOBACCO: SMOKING
TOBACCO: SMOKING One in 4 adults in Guam is a smoker. Among youth, 1 in 5 smokes. Guam s smoking rate is higher than most US States and Territories; this has remained unchanged since 2001. T O B A C C
Lung Cancer Screening
Lung Cancer Screening Middlesex Hospital Total Lung Care Center Megin Iaccarino RN, BSN Lung Pathway Coordinator and Lung Nurse Navigator Middlesex Hospital Cancer Center and Surgical Alliance Lung Screening
ISSUEBrief. Reducing the Burden of Smoking on Employee Health and Productivity. Center for Prevention
Center for Prevention and Health ISSUEBrief Services Volume I, Number 5 Reducing the Burden of Smoking on Employee Health and Productivity This issue brief summarizes information presented during the fifth
Formulating Clinical Questions. Keith Posley, MD Lauren Maggio, MS
Formulating Clinical Questions Keith Posley, MD Lauren Maggio, MS Goals & Objectives At the end of this session you will be able to: Facilitate the upcoming PBL clinical question exercise Formulate an
Cancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine.
Cancer Screening Robert L. Robinson, MD, MS Ambulatory Conference SIU School of Medicine Department of Internal Medicine March 13, 2003 Why screen for cancer? Early diagnosis often has a favorable prognosis
Communicating uncertainty about benefits and
Communicating uncertainty about benefits and harms of pharmaceutical products Lisa M. Schwartz, MD, MS Steven Woloshin, MD, MS The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth
Health Insurance Benefits for Treatment of Tobacco Dependence. Summary
S U M M A R Y R E P O R T O F T H E P A C I F I C C E N T E R O N H E A L T H A N D T O B A C C O Health Insurance Benefits for Treatment of Tobacco Dependence Summary $ Why do tobacco users need health
Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?
Cancer in Primary Care: Prostate Cancer Screening How and How often? Should we and in which patients? PLCO trial (Prostate, Lung, Colorectal and Ovarian) Results In the screening group, rates of compliance
Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS)
Version: February 2013 Fact sheet Lung cancer screening for employees exposed to asbestos using CT screening (CTTS) Dr. med. Susanna Stöhr, PD Dr. med. Dr. phil. David Miedinger, Dr. med. Marcel Jost 1.
PROSTATE CANCER SCREENING PROSTATE CANCER SCREENING
3:45 4:45pm Screening Guidelines for Men's Health SPEAKER Radha Rao, MD Presenter Disclosure Information The following relationships exist related to this presentation: Radha Rao, MD: No financial relationships
Lung Cancer Screening: An Update for the U.S. Preventive Services Task Force
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ
Tobacco Control in India
Tobacco Control in India K R Thankappan MD, MPH Professor Achutha Menon Centre for Health Science Studies Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, India
VISION MISSION GOAL AND OBJECTIVES
VISION MISSION GOAL AND OBJECTIVES 3. Vision, Mission, Goal and Objectives 3.1. Vision To create a tobacco-free society 3.2. Mission 3.3. Goal To promote individual, community and government responsibility
4/8/13. Pre-test Audience Response. Prostate Cancer 2012. Screening and Treatment of Prostate Cancer: The 2013 Perspective
Pre-test Audience Response Screening and Treatment of Prostate Cancer: The 2013 Perspective 1. I do not offer routine PSA screening, and the USPSTF D recommendation will not change my practice. 2. In light
Cancer in North Carolina 2013 Report
Cancer in North Carolina 2013 Report January 2014 Updated by Central Cancer Registry Cancer in North Carolina Purpose Cancer is the leading cause of death in North Carolina even though cancer mortality
Lung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD
Public Outcomes Report Lung Cancer Submitted by Omar A. Majid, MD Lung cancer is the most common cancer-related cause of death among men and women. It has been estimated that there will be 226,1 new cases
Asbestos related cancers
New cancer cases 1954-215 in Finland, Men Pukkala et al. 26 Asbestos related cancers Panu Oksa, MD, docent Course on asbestos-related diseases Tartu 4-5.12.26 Asbestos related cancer / FIOH / PO / 1.1.27
Final Frequencies (n=1,002) NATIONAL ONLINE SURVEY The Mellman Group, Inc. June 19, 2013
Final Frequencies (n=1,002) NATIONAL ONLINE SURVEY The Mellman Group, Inc. June 19, 2013 Are you female or male? male... 48 female... 52 In which state are you registered to vote? [PROVIDE LIST OF STATES
Chapter 7: Effect Modification
A short introduction to epidemiology Chapter 7: Effect Modification Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand Chapter 8 Effect modification Concepts of interaction
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
The Evaluation of Cancer Control Interventions in Lung Cancer Using a Canadian Cancer Risk Management Model
The Evaluation of Cancer Control Interventions in Lung Cancer Using a Canadian Cancer Risk Management Model WK Evans, M Wolfson, WM Flanagan, J Shin, FF Liu JR Goffin, K Asakawa, N Mittmann, L Fairclough
Why should the Framework Convention on Tobacco-Control be approved?
Why should the Framework Convention on Tobacco-Control be approved? For many years, smoking was seen as a choice for a lifestyle. However, today this is acknowledged by Science as a disease caused by addiction
YOU CAN QUIT YOUR TOBACCO USE
YOU CAN QUIT YOUR TOBACCO USE Learn how to get help to quit using tobacco and improve your chances of quitting. This document explains the best ways to quit tobacco use as well as new treatments to help.
Stop-smoking battle still raging 50 years after surgeon general published health risks
Stop-smoking battle still raging 50 years after surgeon general published health risks By Lois M. Collins, Deseret News National Edition Published: Saturday, Jan. 11 2014 8:20 p.m. MST A half-century ago,
Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies
Breast Cancer Screening in Low- and Middle-Income Countries A Framework To Choose Screening Strategies Richard Wender, MD Session code: www.worldcancercongress.org A Five Step Framework to Guide Screening
WHY THE FDA SHOULD REGULATE TOBACCO PRODUCTS
WHY THE FDA SHOULD REGULATE TOBACCO PRODUCTS WHAT IF a product consumed by nearly 50 million Americans every day killed one-third of those who became regular users and one-half of those who use it for
ONLINE CONTINUING EDUCATION ACTIVITY
ARTICLE TITLE: American Cancer Society Lung Cancer Screening Guidelines ONLINE CONTINUING EDUCATION ACTIVITY Take free quizzes online at acsjournals.com/ce CONTINUING MEDICAL EDUCATION ACCREDITATION AND
Big Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
Cancer Screening and Early Detection Guidelines
Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical
1. To create a comprehensive Benchmark plan that will assure maximum tobacco cessation coverage to all populations in Rhode Island:
POSTION STATEMENT Submitted to the Rhode Island Health Benefits Exchange Submitted By the Public Policy Workgroup of the Statewide Tobacco Cessation Committee on Tobacco Cessation Treatment Benchmarks
Lungenkrebs. Lungenkrebs Häufigkeit
Lungenkrebs Prof. Dr. E.W. Russi Pneumologie 1.9.2008 Lungenkrebs Häufigkeit The Principles and Practice of Medicine William Osler New York D. Appleton and Company 1892 Section IV DISEASE OF THE RESPIRATORY
Journal of. Employee Assistance. The magazine of the Employee Assistance Professionals Association VOL. 36 NO. 2 2 ND QUARTER 2006
Employer Initiatives to Stop Smoking by Mary Hill, LCSW, CEAP As more employers take aggressive steps to reduce health care costs arising from employees tobacco use, EAPs can and must help ensure the process
Non-Small Cell Lung Cancer Therapies
Non-Small Cell Lung Cancer Therapies Guest Expert: Roy, MD, PhD Assistant Professor of Therapeutic Radiology Scott, MD Assistant Professor of Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome
The Impact of Alcohol
Alcohol and Tobacco Smoking cigarettes and drinking alcohol are behaviors that often begin in adolescence. Although tobacco companies are prohibited from advertising, promoting, or marketing their products
Smoking Cessation: Treatment Options for Nicotine Addiction
Smoking Cessation: Treatment Options for Nicotine Addiction Hilary Nierenberg, NP, MPH Center for Interventional Vascular Therapy Columbia University Medical Center Disclosure Statement of Financial Interest
PSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Facing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer.
Facing Lung Cancer? Learn why da Vinci Surgery may be your best treatment option for lung cancer. The Condition: Lung Cancer The lung is the organ that moves oxygen through your body. You have two lungs
Primary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
Low Dose CT Screening for Lung Cancer
Low Dose CT Screening for Lung Cancer Donna Edmondson, MSN, CRNP, AOCNP Division of Thoracic and Esophageal Surgery Fox Chase Cancer Center Philadelphia, PA Rohit Kumar, MD Assistant Professor of Medicine
Introduction To Evidence-Based Practice. Keith Posley, MD Lauren Maggio, MS (LIS)
Introduction To Evidence-Based Practice Keith Posley, MD Lauren Maggio, MS (LIS) Goals & Objectives Define Evidence-Based Medicine (EBM) Articulate the four steps of EBP Learn to formulate answerable clinical
You Can Quit Smoking. U.S. Department of Health and Human Services Public Health Service
You Can Quit Smoking C O N S U M E R G U I D E U.S. Department of Health and Human Services Public Health Service NICOTINE: A POWERFUL ADDICTION If you have tried to quit smoking, you know how hard it
SMOKING CESSATION. Presented by your Cigna Employee Assistance Program (EAP)
SMOKING CESSATION Presented by your Cigna Employee Assistance Program (EAP) SEMINAR GOALS Understand your tobacco use habit Learn health consequences of smoking and tobacco use Become familiar with smoking
Smoking Cessation Program
Smoking Cessation Program UHN Information for people who are ready to quit smoking Read this information to learn: why you should quit smoking how the Smoking Cessation Program works treatments to help
The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options
Why We re Here The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options What Are Lungs? What Do They Do? 1 Located in the chest Allow you to breathe Provide oxygen
Lung cancer forms in tissues of the lung, usually in the cells lining air passages.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
Clinical Trials Network
National Drug Abuse Treatment Clinical Trials Network STOP SMOKING STUDY Should I Join? NATIONAL INSTITUTES OF HEALTH U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Introduction Many people who abuse drugs
Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
Lung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
Measures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
Male. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
LOW DOSE CT LUNG CANCER SCREENING: IT S TIME HAS COME. Andrew D. Nish MD
LOW DOSE CT LUNG CANCER SCREENING: IT S TIME HAS COME Andrew D. Nish MD OBJECTIVES Understand the controversies of screening for cancer control in a large population Understand primary and secondary prevention
Quit & Get Fit! Frequently Asked Questions For Personal Trainers (November 2011)
Quit & Get Fit! Frequently Asked Questions For Personal Trainers (November 2011) What is Quit & Get Fit? Quit & Get Fit is an initiative of the Ontario Lung Association, made possible through funding from
WHO PACKAGE OF SIX EVIDENCE-BASED TOBACCO CONTROL MEASURES THAT ARE PROVEN TO REDUCE TOBACCO USE AND SAVE LIVES
About 1.2 billion smokers are currently in the world. Tobacco consumption has led to a 100 million deaths in the last century, and statistics indicate estimated to rise to 1,000 million deaths by the end
Better Living with Obstructive Pulmonary Disease A Patient Guide
Better Living with Obstructive Pulmonary Disease A Patient Guide Second Edition November 2012 Queensland Health The State of Queensland (Queensland Health) and The Australian Lung Foundation 2012 a Better
Health Professionals Survey on Tobacco Use and Cessation Counseling -- Lebanon 2005
Health Professionals Survey on Tobacco Use and Cessation Counseling -- Lebanon 2005 Georges Saade (1) Charles W Warren (2) Nathan R Jones (2) Ali Mokdad (3) Samira Asma (2) (1) Non Communicable Disease
Primary care: Addictive disorders. Addiction a growing public health problem
Meditation, Addiction, and the Culture of Patient Satisfaction: An Evolving Primary Care Research Strategy Department of Family Medicine Aleksandra Zgierska, MD PhD UW School of Medicine & Public Health
How To Treat Lung Cancer At Cleveland Clinic
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
An Update on Lung Cancer Diagnosis
An Update on Lung Cancer Diagnosis Dr Michael Fanning MBBS FRACGP FRACP RESPIRATORY AND SLEEP PHYSICIAN Mater Medical Centre Outline Risk factors for lung cancer Screening for lung cancer Radiologic follow-up
2009 Cancer Committee
2009 Cancer Committee Lung (non-small cell) Cancer Study Stage IIIA and IIIB John Clouse, M.D. Alicia Stark, RHIT Jeff Robinson Table of Cont ent s Table of Contents... 1 Lung (non-small cell) Cancer Facts.2
Marijuana: It s Legal, Now What? A Dialogue About America's Changing Attitudes, Laws and What This Means for Families
Marijuana: It s Legal, Now What? A Dialogue About America's Changing Attitudes, Laws and What This Means for Families A Marijuana Attitudes Survey Report Summary Released: July 16, 2013 Background: With
Controversites: Screening for Prostate Cancer in Older Adults
Controversites: Screening for Prostate Cancer in Older Adults William Dale, MD, PhD University of Chicago Sections of Geriatrics & Palliative Medicine and Hematology/Oncology Director, Specialized Oncology
WA Asbestos Review Program
WA Asbestos Review Program Dr Fraser Brims Consultant Respiratory Physician, SCGH, Head of Occupational and Respiratory Health Unit, LIWA Asbestos awareness week seminar, 2014 Introduction Asbestos and
The VEdeTTE cohort study: Effectiveness of treatments for heroin addiction in retaining patients and reducing mortality
The VEdeTTE cohort study: Effectiveness of treatments for heroin addiction in retaining patients and reducing mortality Federica Vigna-Taglianti www.oed.piemonte.it Piedmont Centre for Drug Addiction Epidemiology
Lung Cancer Awareness Month Update
Lung Cancer Awareness Month Update Guest Expert: Frank, MD Professor of Thoracic Surgery Lynn, MD Professor of Pulmonary Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers
What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide
What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide A M E R I C A N C O L L E G E O F C H E S T P H Y S I C I A N S Lung cancer is one of the most common cancers. About 170,000
Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer
Asbestos Health Risks Dr Andrew Pengilley Acting Chief Health Officer Asbestos Asbestos is a name given to several different fibrous minerals Three main commercial types are Chrysotile (white asbestos)
Asbestos Related Diseases
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through
Drug Free Campus Plan
Baptist University of the Américas, San Antonio, Texas, is committed to maintaining a drug free environment, free of the abuse of alcohol, tobacco and other drugs. Baptist University of the Américas is
Butler Memorial Hospital Community Health Needs Assessment 2013
Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community
Tobacco Addiction. Presented by: Dawn M. Dunn, M.P.H. & Dotsie Anfenson
Tobacco Addiction Presented by: Dawn M. Dunn, M.P.H. & Dotsie Anfenson Presentation Overview Tobacco Use: The Realities Nicotine Addiction Pharmacological Treatments Tobacco Use: Assessing CA s Progress
Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.
Proposed PAHO Plan of Action for Cancer Prevention and Control 2008 2015 Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.
Do Taxes Really Affect the Consumption of Cigarettes?
Do Taxes Really Affect the Consumption of Cigarettes? Patrick C. Gallagher, Elon College The issue of smoking has recently been under close scrutiny by the government. Tobacco companies have been blamed
Position Statement: Nicotine Dependence
Position Statement: Nicotine Dependence I. Treatment and Prevention In accordance with the avowed purposes of NAADAC, The Association for Addiction Professionals prompting and supporting the most appropriate
I choose to be smoke-free. A Workplace Guide for Employers
I choose to be smoke-free. A Workplace Guide for Employers Committed to a Healthier Mississippi. Table of Contents Preface...1 Questions & Answers...2-3!...4-10 Sample Workplace Survey...11 The scientific
INTRODUCTION. Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report - March 2011
TPCP Tobacco Prevention & Cessation Program Substance Abuse and Tobacco Cessation Report Report Prepared by Antionne Dewayne Alcorn, BS, CPC, CIT Contributors Miriam N Karanja, MBA Ma rc h 2 0 1 1 INTRODUCTION
Introduction to Public Health: Explaining Its Role in Disasters
Introduction to Public Health: Explaining Its Role in Disasters Objectives By the end of this section, the participant should be able to: State the mission of public health Describe the role of public
Cigna Medical Coverage Policy
Cigna Medical Coverage Policy Subject Low-Dose Computed Tomography for Lung Cancer Screening Effective Date... 2/15/2014 Next Review Date... 2/15/2015 Coverage Policy Number... 0007 Table of Contents Coverage
Saving Lives, Saving Money. A state-by-state report on the health and economic impact of comprehensive smoke-free laws
Saving Lives, Saving Money A state-by-state report on the health and economic impact of comprehensive smoke-free laws 2011 Table of Contents Executive Summary...............................................................................2
Formulating Research Questions. School of Health Sciences and Social Work
Formulating Research Questions EBP steps Formulate a clinically relevant and answerable question Find the best evidence Evaluate the evidence Integrate with clinical expertise and patient values and apply
L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
Parisa Vatanka, PharmD Pharmacy Strategic Alliances Manager Assistant Clinical Professor, UCSF. Stan Leung, PharmD Clinical Division Lead
Parisa Vatanka, PharmD Pharmacy Strategic Alliances Manager Assistant Clinical Professor, UCSF Stan Leung, PharmD Clinical Division Lead April 13, 2015 ! PrevenFve Care Immuniza(ons (aligned with ACIP
co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center
Cancer is a group of more than 100 related diseases. Normally, cells grow and divide to produce more cells to keep the body healthy. Sometimes, this process goes wrong. New cells form when the body doesn
Leading the Way to Treat Liver Cancer
Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale
Lung Cancer in Vermont
Lung Cancer in Vermont Vermont Cancer Registry Chronic Disease Epidemiology November 2010 Vermont Facts Incidence: Lung cancer is the second most commonly diagnosed cancer in Vermont; approximately 260
hoosier stories of success in cancer prevention & control
The ICC is proud of the accomplishments of our partner organizations, and is aware of the impact these accomplishments have in saving lives and building a sustainable direction for cancer prevention and
Integrating Health & Wellness & Peers in Clubhouse Programs
Integrating Health & Wellness & Peers in Clubhouse Programs Colleen McKay, M.A., C.A.G.S. Program for Clubhouse Research Systems and Psychosocial Advances Research Center University of Massachusetts Medical
Lung Cancer Surveillance using low Dose CT scanning Where are We Now?
Lung Cancer urveillance using low Dose CT scanning Where are We Now? cott wanson Professor Thoracic urgery Brigham and Women s Hospital and Harvard Medical chool Disclosures These slides were kindly provided
Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015
Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3